{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:48:23Z","timestamp":1789087703626,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82002096"],"award-info":[{"award-number":["82002096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82002101"],"award-info":[{"award-number":["82002101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2023AFB825"],"award-info":[{"award-number":["2023AFB825"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","award":["2023A15"],"award-info":[{"award-number":["2023A15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04366-6","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:16:33Z","timestamp":1776734193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["mRNA nanotherapeutics for sepsis: immune modulation strategies and translational challenges"],"prefix":"10.1186","volume":"24","author":[{"given":"Yukun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4366_CR1","doi-asserted-by":"crossref","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u2013810.","DOI":"10.1001\/jama.2016.0287"},{"issue":"2","key":"4366_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1254\/fpj.23040","volume":"159","author":"K Sakamoto","year":"2024","unstructured":"Sakamoto K, Kurokawa J. [Pathophysiology of skeletal muscle during sepsis]. Nihon Yakurigaku Zasshi. 2024;159(2):112\u20137.","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"7","key":"4366_CR3","doi-asserted-by":"publisher","first-page":"e0270711","DOI":"10.1371\/journal.pone.0270711","volume":"17","author":"M Rababa","year":"2022","unstructured":"Rababa M, Bani Hamad D, Hayajneh AA. Sepsis assessment and management in critically ill adults: a systematic review. PLoS One. 2022;17(7):e0270711.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"4366_CR4","first-page":"67","volume":"61","author":"I Srzic","year":"2022","unstructured":"Srzic I, Nesek Adam V, Tunjic Pejak D. Sepsis definition: what\u2019s new in the treatment guidelines. Acta Clin Croat. 2022;61(Suppl 1):67\u201372.","journal-title":"Acta Clin Croat"},{"issue":"7","key":"4366_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/00325481.2024.2388021","volume":"136","author":"L Desposito","year":"2024","unstructured":"Desposito L, Bascara C. Review: sepsis guidelines and core measure bundles. Postgrad Med. 2024;136(7):702\u201311.","journal-title":"Postgrad Med"},{"issue":"Suppl 2","key":"4366_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00063-023-01088-7","volume":"118","author":"C Fleischmann-Struzek","year":"2023","unstructured":"Fleischmann-Struzek C, Rudd K. Challenges of assessing the burden of sepsis. Med Klin Intensivmed Notfmed. 2023;118(Suppl 2):68\u201374.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"2","key":"4366_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/CNQ.0000000000000552","volume":"48","author":"T Marshall","year":"2025","unstructured":"Marshall T, Dysert K, Young M, DuMont T. Pathophysiology of sepsis. Crit Care Nurs Q. 2025;48(2):88\u201392.","journal-title":"Crit Care Nurs Q"},{"issue":"6","key":"4366_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/ajhp\/zxab393","volume":"79","author":"J Jacobi","year":"2022","unstructured":"Jacobi J. The pathophysiology of sepsis \u2013 2021 update: part 2, organ dysfunction and assessment. Am J Health-Syst Pharm. 2022;79(6):424\u201336.","journal-title":"Am J Health-Syst Pharm"},{"issue":"4","key":"4366_CR9","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20198595","volume":"52","author":"R Salomao","year":"2019","unstructured":"Salomao R, Ferreira BL, Salomao MC, Santos SS, Azevedo LCP, Brunialti MKC. Sepsis: evolving concepts and challenges. Braz J Med Biol Res. 2019;52(4):e8595.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"4366_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2302\/kjm.71-001-ABST","volume":"71","author":"K Kariko","year":"2022","unstructured":"Kariko K. Developing mRNA for therapy. Keio J Med. 2022;71(1):31.","journal-title":"Keio J Med"},{"issue":"16","key":"4366_CR11","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1039\/D2TB02782H","volume":"11","author":"DW Zhou","year":"2023","unstructured":"Zhou DW, Wang K, Zhang YA, Ma K, Yang XC, Li ZY, Yu SS, Chen KZ, Qiao SL. mRNA therapeutics for disease therapy: principles, delivery, and clinical translation. J Mater Chem B. 2023;11(16):3484\u2013510.","journal-title":"J Mater Chem B"},{"issue":"9","key":"4366_CR12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1517\/14712598.2015.1057563","volume":"15","author":"H Youn","year":"2015","unstructured":"Youn H, Chung JK. Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy. Expert Opin Biol Ther. 2015;15(9):1337\u201348.","journal-title":"Expert Opin Biol Ther"},{"key":"4366_CR13","first-page":"1","volume":"372","author":"M Qureischi","year":"2022","unstructured":"Qureischi M, Mohr J, Arellano-Viera E, Knudsen SE, Vohidov F, Garitano-Trojaola A. mRNA-based therapies: preclinical and clinical applications. Int Rev Cell Mol Biol. 2022;372:1\u201354.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"5","key":"4366_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","volume":"7","author":"AM Reichmuth","year":"2016","unstructured":"Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319\u201334.","journal-title":"Ther Deliv"},{"issue":"2","key":"4366_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7150\/thno.84291","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Qi J, Wang J, Hu W, Zhou W, Wang Y, et al. Nanoparticle technology for mRNA: delivery strategy, clinical application and developmental landscape. Theranostics. 2024;14(2):738\u201360.","journal-title":"Theranostics"},{"issue":"1","key":"4366_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01478-7","volume":"20","author":"SH Kiaie","year":"2022","unstructured":"Kiaie SH, Majidi Zolbanin N, Ahmadi A, Bagherifar R, Valizadeh H, Kashanchi F, et al. Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. J Nanobiotechnology. 2022;20(1):276.","journal-title":"J Nanobiotechnology"},{"key":"4366_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186582","author":"S Xu","year":"2020","unstructured":"Xu S, Yang K, Li R, Zhang L. mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection. Int J Mol Sci. 2020;21(18):6582. https:\/\/doi.org\/10.3390\/ijms21186582","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4366_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","volume":"27","author":"PS Kowalski","year":"2019","unstructured":"Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol Ther. 2019;27(4):710\u201328.","journal-title":"Mol Ther"},{"issue":"1","key":"4366_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Ther. 2022;7(1):166.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"4366_CR20","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner E, Yang R, Foo KS, Goedel A, Chien KR. Unlocking the promise of mRNA therapeutics. Nat Biotechnol. 2022;40(11):1586\u2013600.","journal-title":"Nat Biotechnol"},{"key":"4366_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v15030668","author":"F Cheng","year":"2023","unstructured":"Cheng F, Wang Y, Bai Y, Liang Z, Mao Q, Liu D, et al. Research Advances on the Stability of mRNA Vaccines. Viruses. 2023. https:\/\/doi.org\/10.3390\/v15030668.","journal-title":"Viruses"},{"issue":"11","key":"4366_CR22","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.7150\/thno.98487","volume":"14","author":"HP Yu","year":"2024","unstructured":"Yu HP, Liu FC, Chung YK, Alalaiwe A, Sung CT, Fang JY. Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries. Theranostics. 2024;14(11):4411\u201337.","journal-title":"Theranostics"},{"key":"4366_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejphar.2018.06.031","volume":"833","author":"Y Hattori","year":"2018","unstructured":"Hattori Y, Hattori K, Suzuki T, Palikhe S, Matsuda N. Nucleic-acid based gene therapy approaches for sepsis. Eur J Pharmacol. 2018;833:403\u201310.","journal-title":"Eur J Pharmacol"},{"key":"4366_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114139","volume":"386","author":"Y Louaguenouni","year":"2025","unstructured":"Louaguenouni Y, Mansart A, Annane D, Fattal E, Fay F. Nanoparticle-based approaches for sepsis treatment: current trends and perspectives. J Control Release. 2025;386:114139.","journal-title":"J Control Release"},{"issue":"3","key":"4366_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s15010-025-02486-z","volume":"53","author":"GG L","year":"2025","unstructured":"L GG, Schramm W, Seitz R. Viral sepsis - pathophysiology and disease manifestation. Infection. 2025;53(3):775\u201384.","journal-title":"Infection"},{"key":"4366_CR26","doi-asserted-by":"crossref","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450\u201364.","DOI":"10.1016\/j.immuni.2021.10.012"},{"key":"4366_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147770","author":"T Srdic","year":"2024","unstructured":"Srdic T, Durasevic S, Lakic I, Ruzicic A, Vujovic P, Jevdovic T, et al. From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction. Int J Mol Sci. 2024;25(14):7770. https:\/\/doi.org\/10.3390\/ijms25147770","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4366_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/1744666X.2021.1875820","volume":"17","author":"EDS Corneo","year":"2021","unstructured":"Corneo EDS, Michels M, Dal-Pizzol F. Sepsis, immunosuppression and the role of epigenetic mechanisms. Expert Rev Clin Immunol. 2021;17(2):169\u201376.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"4366_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14787210.2022.2040359","volume":"20","author":"RR Watkins","year":"2022","unstructured":"Watkins RR, Bonomo RA, Rello J. Managing sepsis in the era of precision medicine: challenges and opportunities. Expert Rev Anti-Infect Ther. 2022;20(6):871\u201380.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"2","key":"4366_CR30","first-page":"e54275","volume":"16","author":"H Reddy","year":"2024","unstructured":"Reddy H, Javvaji CK, Malali S, Kumar S, Acharya S, Toshniwal S. Navigating the cytokine storm: a comprehensive review of chemokines and cytokines in sepsis. Cureus. 2024;16(2):e54275.","journal-title":"Cureus"},{"key":"4366_CR31","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.intimp.2020.107087","volume":"89","author":"V Kumar","year":"2020","unstructured":"Kumar V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020;89:107087. (Pt B).","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4366_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01377-0","volume":"14","author":"A Borges","year":"2024","unstructured":"Borges A, Bento L. Organ crosstalk and dysfunction in sepsis. Ann Intensive Care. 2024;14(1):147.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"4366_CR33","volume":"11","author":"T Gong","year":"2024","unstructured":"Gong T, Liu YT, Fan J. Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction. Mil Med Res. 2024;11(1):24.","journal-title":"Mil Med Res"},{"key":"4366_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711939","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen W, Gong F, Chen Y, Chen E. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review. Front Immunol. 2021;12:711939.","journal-title":"Front Immunol"},{"issue":"5","key":"4366_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4049\/jimmunol.2300171","volume":"211","author":"EE Silva","year":"2023","unstructured":"Silva EE, Skon-Hegg C, Badovinac VP, Griffith TS. The calm after the storm: implications of sepsis immunoparalysis on host immunity. J Immunol. 2023;211(5):711\u20139.","journal-title":"J Immunol"},{"key":"4366_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","volume":"84","author":"LK Torres","year":"2022","unstructured":"Torres LK, Pickkers P, van der Poll T. Sepsis-induced immunosuppression. Annu Rev Physiol. 2022;84:157\u201381.","journal-title":"Annu Rev Physiol"},{"key":"4366_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071011","author":"C Nedeva","year":"2021","unstructured":"Nedeva C. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis. Biomolecules. 2021;11(7):1011. https:\/\/doi.org\/10.3390\/biom11071011","journal-title":"Biomolecules"},{"key":"4366_CR38","doi-asserted-by":"publisher","first-page":"1328667","DOI":"10.3389\/fimmu.2024.1328667","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang C, Liu J, Wu Q, Wang Z, Hu B, Bo L. The role of TIM-3 in sepsis: a promising target for immunotherapy? Front Immunol. 2024;15:1328667.","journal-title":"Front Immunol"},{"key":"4366_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2147\/IJGM.S402586","volume":"16","author":"L Wang","year":"2023","unstructured":"Wang L, Zhang Z, Chen X, Yu F, Huang H, Shen X, Tan Y, Wu Q. Relationship Between the Expression of PD-1 and CTLA-4 on T Lymphocytes and the Severity and Prognosis of Sepsis. Int J Gen Med. 2023;16:1513\u201325.","journal-title":"Int J Gen Med"},{"key":"4366_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1029438","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T, Yu-Jing L, Ma T. Role of regulation of PD-1 and PD-L1 expression in sepsis. Front Immunol. 2023;14:1029438.","journal-title":"Front Immunol"},{"issue":"1","key":"4366_CR41","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56.","journal-title":"Mil Med Res"},{"key":"4366_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1434688","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Yuan S, Zhang J. The potential immunological mechanisms of sepsis. Front Immunol. 2024;15:1434688.","journal-title":"Front Immunol"},{"issue":"8","key":"4366_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/anae.16263","volume":"79","author":"RC Robey","year":"2024","unstructured":"Robey RC, Logue C, Caird CA, Hansel J, Hellyer TP, Simpson J, Dark P, Mathioudakis AG, Felton T. Immunomodulatory drugs in sepsis: a systematic review and meta-analysis. Anaesthesia. 2024;79(8):869\u201379.","journal-title":"Anaesthesia"},{"issue":"1","key":"4366_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02203-w","volume":"29","author":"J Luo","year":"2024","unstructured":"Luo J, Zhang C, Chen D, Chang T, Chen S, Lin Z, et al. Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression. Eur J Med Res. 2024;29(1):583.","journal-title":"Eur J Med Res"},{"issue":"1","key":"4366_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov. 2023;9(1):465.","journal-title":"Cell Death Discov"},{"key":"4366_CR46","doi-asserted-by":"publisher","first-page":"12529","DOI":"10.2147\/IJN.S496456","volume":"19","author":"L Lin","year":"2024","unstructured":"Lin L, Liu H, Zhang D, Du L, Zhang H. Nanolevel immunomodulators in sepsis: novel roles, current perspectives, and future directions. Int J Nanomed. 2024;19:12529\u201356.","journal-title":"Int J Nanomed"},{"key":"4366_CR47","doi-asserted-by":"crossref","unstructured":"Mirijello A, Tosoni A. G. On Behalf Of The Internal Medicine Sepsis Study, New Strategies for Treatment of Sepsis. Med (Kaunas) 56(10) (2020).","DOI":"10.3390\/medicina56100527"},{"key":"4366_CR48","doi-asserted-by":"crossref","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25(1):19\u201328.","DOI":"10.1038\/s41590-023-01660-5"},{"issue":"1","key":"4366_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01335-5","volume":"20","author":"L Miao","year":"2021","unstructured":"Miao L, Zhang Y, Huang L. MRNA vaccine for cancer immunotherapy. Mol Cancer. 2021;20(1):41.","journal-title":"Mol Cancer"},{"issue":"8","key":"4366_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1384","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Wang M, Peng X, Yang Y, Chen Q, Liu J, et al. MRNA vaccine in cancer therapy: current advance and future outlook. Clin Transl Med. 2023;13(8):e1384.","journal-title":"Clin Transl Med"},{"issue":"1","key":"4366_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2024.2333123","volume":"21","author":"Y Mochida","year":"2024","unstructured":"Mochida Y, Uchida S. MRNA vaccine designs for optimal adjuvanticity and delivery. RNA Biol. 2024;21(1):1\u201327.","journal-title":"RNA Biol"},{"issue":"10","key":"4366_CR52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin U, Kariko K, Tureci O. MRNA-based therapeutics\u2013developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759\u201380.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4366_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2533\/chimia.2019.391","volume":"73","author":"M Tusup","year":"2019","unstructured":"Tusup M, French LE, De Matos M, Gatfield D, Kundig T, Pascolo S. Design of in vitro transcribed mRNA vectors for research and therapy. CHIMIA. 2019;73(5):391\u20134.","journal-title":"CHIMIA"},{"issue":"1","key":"4366_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108015","volume":"301","author":"L Jin","year":"2025","unstructured":"Jin L, Zhou Y, Zhang S, Chen SJ. MRNA vaccine sequence and structure design and optimization: advances and challenges. J Biol Chem. 2025;301(1):108015.","journal-title":"J Biol Chem"},{"issue":"9","key":"4366_CR55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","volume":"16","author":"C Iavarone","year":"2017","unstructured":"Iavarone C, O\u2019Hagan T, Yu DD, Delahaye NF, Ulmer JB. Mechanism of action of mRNA-based vaccines. Expert Rev Vaccines. 2017;16(9):871\u201381.","journal-title":"Expert Rev Vaccines"},{"key":"4366_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114002","volume":"179","author":"O Chabanovska","year":"2021","unstructured":"Chabanovska O, Galow AM, David R, Lemcke H. mRNA - a game changer in regenerative medicine, cell-based therapy and reprogramming strategies. Adv Drug Deliv Rev. 2021;179:114002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"44","key":"4366_CR57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2304966120","volume":"120","author":"Z Tang","year":"2023","unstructured":"Tang Z, You X, Xiao Y, Chen W, Li Y, Huang X, et al. Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection. Proc Natl Acad Sci U S A. 2023;120(44):e2304966120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4366_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73755-0","volume":"10","author":"CA Lissandrello","year":"2020","unstructured":"Lissandrello CA, Santos JA, Hsi P, Welch M, Mott VL, Kim ES, et al. High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing. Sci Rep. 2020;10(1):18045.","journal-title":"Sci Rep"},{"key":"4366_CR59","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.actbio.2024.03.031","volume":"181","author":"W Huang","year":"2024","unstructured":"Huang W, Fu G, Wang Y, Chen C, Luo Y, Yan Q, Liu Y, Mao C. Immunometabolic reprogramming of macrophages with inhalable CRISPR\/Cas9 nanotherapeutics for acute lung injury intervention. Acta Biomater. 2024;181:308\u201316.","journal-title":"Acta Biomater"},{"key":"4366_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/v16010120","author":"L Wei","year":"2024","unstructured":"Wei L, Dong C, Zhu W, Wang BZ. mRNA Vaccine Nanoplatforms and Innate Immunity. Viruses. 2024;16(1):120. https:\/\/doi.org\/10.3390\/v16010120","journal-title":"Viruses"},{"key":"4366_CR61","doi-asserted-by":"crossref","unstructured":"Liu X, Zhang X, Li J, Meng H. Enrichment of nano delivery platforms for mRNA-based nanotherapeutics, Med Rev (2021) 3(4) (2023) 356\u2013361.","DOI":"10.1515\/mr-2023-0010"},{"issue":"9","key":"4366_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202200801","volume":"24","author":"T Ma","year":"2023","unstructured":"Ma T, Chen X, Wang M. Intracellular delivery of mRNA for cell-selective CRISPR\/Cas9 genome editing using lipid nanoparticles. Chembiochem. 2023;24(9):e202200801.","journal-title":"Chembiochem"},{"issue":"1","key":"4366_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00950-y","volume":"7","author":"E Fang","year":"2022","unstructured":"Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther. 2022;7(1):94.","journal-title":"Signal Transduct Target Ther"},{"key":"4366_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586.","journal-title":"Int J Pharm"},{"key":"4366_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061593","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patricio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Pharmaceutics"},{"issue":"8","key":"4366_CR66","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1021\/acsnano.7b04734","volume":"11","author":"S Rietwyk","year":"2017","unstructured":"Rietwyk S, Peer D. Next-generation lipids in RNA interference therapeutics. ACS Nano. 2017;11(8):7572\u201386.","journal-title":"ACS Nano"},{"issue":"3","key":"4366_CR67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/nat.2018.0721","volume":"28","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni JA, Cullis PR, van der Meel R. Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucleic Acid Ther. 2018;28(3):146\u201357.","journal-title":"Nucleic Acid Ther"},{"issue":"1","key":"4366_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26926-0","volume":"12","author":"M Packer","year":"2021","unstructured":"Packer M, Gyawali D, Yerabolu R, Schariter J, White P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat Commun. 2021;12(1):6777.","journal-title":"Nat Commun"},{"key":"4366_CR69","doi-asserted-by":"crossref","unstructured":"Xiao Y, Lian X, Sun Y, Sung YC, Vaidya A, Chen Z, Gupta A, Chatterjee S, Zheng L, Guerrero E, Wang X, Farbiak L, Yang Y, Diamond MI, Leal C, McDonald JG, Siegwart DJ. High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics. Nat Mater 2025;24(11):1840\u20131851.","DOI":"10.1038\/s41563-024-02116-3"},{"key":"4366_CR70","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.04.430128","author":"S Ndeupen","year":"2021","unstructured":"Ndeupen S, Qin Z, Jacobsen S, Estanbouli H, Bouteau A, Igyarto BZ. The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.03.04.430128.","journal-title":"bioRxiv"},{"key":"4366_CR71","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jconrel.2021.12.027","volume":"344","author":"H Parhiz","year":"2022","unstructured":"Parhiz H, Brenner JS, Patel PN, Papp TE, Shahnawaz H, Li Q, Shi R, Zamora ME, Yadegari A, Marcos-Contreras OA, Natesan A, Pardi N, Shuvaev VV, Kiseleva R, Myerson JW, Uhler T, Riley RS, Han X, Mitchell MJ, Lam K, Heyes J, Weissman D, Muzykantov VR. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE). J Control Release. 2022;344:50\u201361.","journal-title":"J Control Release"},{"issue":"29","key":"4366_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500695","volume":"14","author":"Q Wang","year":"2025","unstructured":"Wang Q, Achour J, Emam L, Louaguenouni Y, Cailleau C, Mercier-Nome F, et al. Pulmonary delivery of siRNA anti-TNFalpha-loaded lipid nanoparticles for rapid recovery in murine acute lung injury. Adv Healthc Mater. 2025;14(29):e00695.","journal-title":"Adv Healthc Mater"},{"key":"4366_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124960","volume":"668","author":"L Cao","year":"2025","unstructured":"Cao L, Du M, Cai M, Feng Y, Miao J, Sun J, et al. Neutrophil membrane-coated nanoparticles for targeted delivery of toll-like receptor 4 siRNA ameliorate LPS-induced acute lung injury. Int J Pharm. 2025;668:124960.","journal-title":"Int J Pharm"},{"issue":"17","key":"4366_CR74","doi-asserted-by":"publisher","first-page":"16539","DOI":"10.1021\/acsnano.3c01814","volume":"17","author":"Q Fei","year":"2023","unstructured":"Fei Q, Shalosky EM, Barnes R, Shukla VC, Xu S, Ballinger MN, et al. Macrophage-targeted lipid nanoparticle delivery of microRNA-146a to mitigate hemorrhagic shock-induced acute respiratory distress syndrome. ACS Nano. 2023;17(17):16539\u201352.","journal-title":"ACS Nano"},{"key":"4366_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jconrel.2021.01.014","volume":"331","author":"AIS van den Berg","year":"2021","unstructured":"van den Berg AIS, Yun CO, Schiffelers RM, Hennink WE. Polymeric delivery systems for nucleic acid therapeutics: approaching the clinic. J Control Release. 2021;331:121\u201341.","journal-title":"J Control Release"},{"issue":"1","key":"4366_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.70002","volume":"17","author":"H Wang","year":"2025","unstructured":"Wang H, Cheng Y. Polymers for mRNA delivery. WIREs Nanomed Nanobiotechnol. 2025;17(1):e70002.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"4366_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-022-00104-y","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2:24. https:\/\/doi.org\/10.1038\/s43586-022-00104-y","journal-title":"Nat Rev Methods Primers"},{"key":"4366_CR78","first-page":"71","volume":"440","author":"C Zeng","year":"2022","unstructured":"Zeng C, Zhang C, Walker PG, Dong Y. Formulation and delivery technologies for mRNA vaccines. Curr Top Microbiol Immunol. 2022;440:71\u2013110.","journal-title":"Curr Top Microbiol Immunol"},{"key":"4366_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071849","author":"M Karayianni","year":"2023","unstructured":"Karayianni M, Sentoukas T, Skandalis A, Pippa N, Pispas S. Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives. Pharmaceutics. 2023;15(7):1849. https:\/\/doi.org\/10.3390\/pharmaceutics15071849","journal-title":"Pharmaceutics"},{"issue":"1","key":"4366_CR80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ymthe.2016.10.006","volume":"25","author":"Q Chen","year":"2017","unstructured":"Chen Q, Qi R, Chen X, Yang X, Wu S, Xiao H, et al. A targeted and stable polymeric nanoformulation enhances systemic delivery of mRNA to tumors. Mol Ther. 2017;25(1):92\u2013101.","journal-title":"Mol Ther"},{"issue":"1","key":"4366_CR81","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/btm2.10004","volume":"1","author":"D Dehaini","year":"2016","unstructured":"Dehaini D, Fang RH, Zhang L. Biomimetic strategies for targeted nanoparticle delivery. Bioeng Transl Med. 2016;1(1):30\u201346.","journal-title":"Bioeng Transl Med"},{"key":"4366_CR82","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jconrel.2022.11.013","volume":"352","author":"EA Ismail","year":"2022","unstructured":"Ismail EA, Devnarain N, Govender T, Omolo CA. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications. J Control Release. 2022;352:1048\u201370.","journal-title":"J Control Release"},{"issue":"5","key":"4366_CR83","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1021\/acs.biomac.2c01465","volume":"24","author":"A Phan","year":"2023","unstructured":"Phan A, Avila H, MacKay JA. Biomimetic SARS-CoV-2 spike protein nanoparticles. Biomacromolecules. 2023;24(5):2030\u201341.","journal-title":"Biomacromolecules"},{"key":"4366_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26165052","author":"CY Beh","year":"2021","unstructured":"Beh CY, Prajnamitra RP, Chen LL, Hsieh PC. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis. Molecules. 2021;26(16):5052. https:\/\/doi.org\/10.3390\/molecules26165052","journal-title":"Molecules"},{"issue":"3","key":"4366_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/SMMD.20230015","volume":"2","author":"Y Li","year":"2023","unstructured":"Li Y, Wang J, Xie J. Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy. Smart Medicine. 2023;2(3):e20230015.","journal-title":"Smart Medicine"},{"issue":"1","key":"4366_CR86","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wan S, Yang S, Hu H, Zhang C, Lai J, et al. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment. J Nanobiotechnology. 2022;20(1):542.","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"4366_CR87","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jpp\/rgad089","volume":"76","author":"M Puccetti","year":"2024","unstructured":"Puccetti M, Pariano M, Schoubben A, Ricci M, Giovagnoli S. Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines. J Pharm Pharmacol. 2024;76(6):592\u2013605.","journal-title":"J Pharm Pharmacol"},{"issue":"80","key":"4366_CR88","doi-asserted-by":"publisher","first-page":"11304","DOI":"10.1039\/C8CC07047D","volume":"54","author":"P Sun","year":"2018","unstructured":"Sun P, Li Z, Wang J, Gao H, Yang X, Wu S, Liu D, Chen Q. Transcellular delivery of messenger RNA payloads by a cationic supramolecular MOF platform. Chem Commun (Camb). 2018;54(80):11304\u20137.","journal-title":"Chem Commun (Camb)"},{"key":"4366_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115115","volume":"203","author":"TI Janjua","year":"2023","unstructured":"Janjua TI, Cao Y, Kleitz F, Linden M, Yu C, Popat A. Silica nanoparticles: a review of their safety and current strategies to overcome biological barriers. Adv Drug Deliv Rev. 2023;203:115115.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"4366_CR90","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1021\/acs.nanolett.2c04486","volume":"23","author":"S Dong","year":"2023","unstructured":"Dong S, Feng Z, Ma R, Zhang T, Jiang J, Li Y, et al. Engineered design of a mesoporous silica nanoparticle-based nanocarrier for efficient mRNA delivery in vivo. Nano Lett. 2023;23(6):2137\u201347.","journal-title":"Nano Lett"},{"issue":"11","key":"4366_CR91","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1021\/acsabm.1c00704","volume":"4","author":"R Kamegawa","year":"2021","unstructured":"Kamegawa R, Naito M, Uchida S, Kim HJ, Kim BS, Miyata K. Bioinspired silicification of mRNA-loaded polyion complexes for macrophage-targeted mRNA delivery. ACS Appl Bio Mater. 2021;4(11):7790\u20139.","journal-title":"ACS Appl Bio Mater"},{"issue":"16","key":"4366_CR92","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1021\/acs.nanolett.4c05615","volume":"25","author":"H Xian","year":"2025","unstructured":"Xian H, Song Y, Qu J, Shi Y, Zhang Y, Wu W, et al. CaClOH-modified silica nanoparticles for mRNA delivery. Nano Lett. 2025;25(16):6365\u201373.","journal-title":"Nano Lett"},{"issue":"17","key":"4366_CR93","doi-asserted-by":"publisher","first-page":"17554","DOI":"10.1021\/acsnano.3c06733","volume":"17","author":"H Shin","year":"2023","unstructured":"Shin H, Kang S, Won C, Min DH. Enhanced local delivery of engineered IL-2 mRNA by porous silica nanoparticles to promote effective antitumor immunity. ACS Nano. 2023;17(17):17554\u201367.","journal-title":"ACS Nano"},{"key":"4366_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2025.109580","volume":"555","author":"S Xiong","year":"2025","unstructured":"Xiong S, Jia Y, Liang X. Polysaccharides coated on mesoporous silica nanoparticles inhibit the inflammatory response for the treatment of sepsis. Carbohydr Res. 2025;555:109580.","journal-title":"Carbohydr Res"},{"key":"4366_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101232","volume":"28","author":"S Fan","year":"2024","unstructured":"Fan S, Zhao D, Wang J, Ma Y, Chen D, Huang Y, et al. Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticles. Mater Today Bio. 2024;28:101232.","journal-title":"Mater Today Bio"},{"issue":"11","key":"4366_CR96","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1248\/yakushi.23-00118","volume":"143","author":"H Maeda","year":"2023","unstructured":"Maeda H. Albumin-based drug delivery system targeting mannose receptors and its application to medical treatments. Yakugaku Zasshi. 2023;143(11):923\u201330.","journal-title":"Yakugaku Zasshi"},{"key":"4366_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102054","volume":"33","author":"Z Li","year":"2025","unstructured":"Li Z, Luo B, Chen Y, Wang L, Liu Y, Jia J, et al. Nanomaterial-based encapsulation of biochemicals for targeted sepsis therapy. Mater Today Bio. 2025;33:102054.","journal-title":"Mater Today Bio"},{"issue":"27","key":"4366_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301243","volume":"12","author":"N Ding","year":"2023","unstructured":"Ding N, Luo G, Li H, Xing C, Gao Y, Xi W, et al. A cyclodextrin-based pH-responsive microRNA delivery platform targeting polarization of M1 to M2 macrophages for sepsis therapy. Adv Healthc Mater. 2023;12(27):e2301243.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"4366_CR99","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.2174\/0929867329666220929152644","volume":"30","author":"R Shen","year":"2023","unstructured":"Shen R, Yuan H. Achievements and bottlenecks of PEGylation in nano-delivery systems. Curr Med Chem. 2023;30(12):1386\u2013405.","journal-title":"Curr Med Chem"},{"issue":"3","key":"4366_CR100","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1021\/acsnano.3c10109","volume":"18","author":"C Tang","year":"2024","unstructured":"Tang C, Jing W, Han K, Yang Z, Zhang S, Liu M, et al. mRNA-laden lipid-nanoparticle-enabled in situ CAR-macrophage engineering for the eradication of multidrug-resistant bacteria in a sepsis mouse model. ACS Nano. 2024;18(3):2261\u201378.","journal-title":"ACS Nano"},{"issue":"1","key":"4366_CR101","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41565-019-0600-1","volume":"15","author":"X Hou","year":"2020","unstructured":"Hou X, Zhang X, Zhao W, Zeng C, Deng B, McComb DW, Du S, Zhang C, Li W, Dong Y. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat Nanotechnol. 2020;15(1):41\u20136.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"4366_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56448-y","volume":"16","author":"JA Meshanni","year":"2025","unstructured":"Meshanni JA, Stevenson ER, Zhang D, Sun R, Ona NA, Reagan EK, et al. Targeted delivery of TGF-beta mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers. Nat Commun. 2025;16(1):1806.","journal-title":"Nat Commun"},{"issue":"2","key":"4366_CR103","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/nat.2022.0049","volume":"33","author":"SD McCarthy","year":"2023","unstructured":"McCarthy SD, Rohde CB, Angel M, Masterson CH, MacLoughlin R, Fandino J, et al. Aerosolized pulmonary delivery of mRNA constructs attenuates severity of Escherichia coli pneumonia in the rat. Nucleic Acid Ther. 2023;33(2):148\u201358.","journal-title":"Nucleic Acid Ther"},{"issue":"1","key":"4366_CR104","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00018-024-05348-3","volume":"81","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhang J, Gao S, Jiang Y, Qu M, Gu J, Wu H, Nan K, Zhang H, Wang J, Chen W, Miao C. Suppression of Skp2 contributes to sepsis-induced acute lung injury by enhancing ferroptosis through the ubiquitination of SLC3A2. Cell Mol Life Sci. 2024;81(1):325.","journal-title":"Cell Mol Life Sci"},{"key":"4366_CR105","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.ircmb.2022.04.010","volume":"372","author":"I Gomez-Aguado","year":"2022","unstructured":"Gomez-Aguado I, Rodriguez-Castejon J, Beraza-Millor M, Rodriguez-Gascon A, Del Pozo-Rodriguez A, Solinis MA. mRNA delivery technologies: toward clinical translation. Int Rev Cell Mol Biol. 2022;372:207\u201393.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"2","key":"4366_CR106","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","volume":"112","author":"E Oude Blenke","year":"2023","unstructured":"Oude Blenke E, Ornskov E, Schoneich C, Nilsson GA, Volkin DB, Mastrobattista E, et al. The storage and in-use stability of mRNA vaccines and therapeutics: not a cold case. J Pharm Sci. 2023;112(2):386\u2013403.","journal-title":"J Pharm Sci"},{"key":"4366_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.101003","volume":"81","author":"M Pandey","year":"2021","unstructured":"Pandey M, Ojha D, Bansal S, Rode AB, Chawla G. From bench side to clinic: potential and challenges of RNA vaccines and therapeutics in infectious diseases. Mol Aspects Med. 2021;81:101003.","journal-title":"Mol Aspects Med"},{"issue":"8","key":"4366_CR108","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu C, Shi Q, Huang X, Koo S, Kong N, Tao W. mRNA-based cancer therapeutics. Nat Rev Cancer. 2023;23(8):526\u201343.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4366_CR109","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol. 2022;40(6):840\u201354.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"4366_CR110","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s13346-023-01362-3","volume":"13","author":"DM Dogbey","year":"2023","unstructured":"Dogbey DM, Torres VES, Fajemisin E, Mpondo L, Ngwenya T, Akinrinmade OA, Perriman AW, Barth S. Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. Drug Deliv Transl Res. 2023;13(11):2719\u201338.","journal-title":"Drug Deliv Transl Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04366-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04366-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04366-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:04:59Z","timestamp":1780916699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04366-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4366"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04366-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No individual personal data is included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}